Analyst firms · Jefferies · MESO

Jefferies MESO price target and rating history

Mesoblast Limited (MESO) · Health Care

Jefferies rates Mesoblast Limited (MESO) Buy, as of its latest action on Nov 25, 2025. It has published 6 rating actions on MESO since December 2022, including 3 upgrades and 3 downgrades.

Current rating

Buy

Price target

Not stated

Median target, all firms

Too few

Actions on MESO

6

Every Jefferies rating on MESO

• Nov 25, 2025
  UpgradeJefferies upgrades to Buy from Hold
• Jul 18, 2025
  DowngradeJefferies downgrades to Hold from Buy
• Dec 23, 2024
  DowngradeJefferies downgrades to Hold from Buy
• Aug 29, 2024
  UpgradeJefferies upgrades to Buy from Hold
• Aug 31, 2023
  UpgradeJefferies upgrades to Buy from Hold
• Dec 6, 2022
  DowngradeJefferies downgrades to Hold from Buy

Questions about Jefferies and MESO

What is Jefferies's rating on MESO?

Jefferies rates MESO Buy, a bullish rating, as of Nov 25, 2025.

When did Jefferies last change its view on MESO?

On Nov 25, 2025, Jefferies upgrades to Buy from Hold.

More MESO rating histories

• Piper Sandler3

All Jefferies ratingsMESO news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.